A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype

Abstract

BackgroundImmune checkpoint blockade (ICB) has been approved for the treatment of triple-negative breast cancer (TNBC), since it significantly improved the progression-free survival (PFS). However, only about 10% of TNBC patients could achieve the complete response (CR) to ICB because of the low response rate and potential adverse reactions to ICB.MethodsOpen datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were downloaded to perform an unsupervised clustering analysis to identify the immune subtype according to the expression profiles. The prognosis, enriched pathways, and the ICB indicators were compared between immune subtypes. Afterward, samples from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) dataset were used to validate the correlation of immune subtype with prognosis. Data from patients who received ICB were selected to validate the correlation of the immune subtype with ICB response. Machine learning models were used to build a visual web server to predict the immune subtype of TNBC patients requiring ICB.ResultsA total of eight open datasets including 931 TNBC samples were used for the unsupervised clustering. Two novel immune subtypes (referred to as S1 and S2) were identified among TNBC patients. Compared with S2, S1 was associated with higher immune scores, higher levels of immune cells, and a better prognosis for immunotherapy. In the validation dataset, subtype 1 samples had a better prognosis than sub type 2 samples, no matter in overall survival (OS) (p = 0.00036) or relapse-free survival (RFS) (p = 0.0022). Bioinformatics analysis identified 11 hub genes (LCK, IL2RG, CD3G, STAT1, CD247, IL2RB, CD3D, IRF1, OAS2, IRF4, and IFNG) related to the immune subtype. A robust machine learning model based on random forest algorithm was established by 11 hub genes, and it performed reasonably well with area Under the Curve of the receiver operating characteristic (AUC) values = 0.76. An open and free web server based on the random forest model, named as triple-negative breast cancer immune subtype (TNBCIS), was developed and is available from https://immunotypes.shinyapps.io/TNBCIS/.ConclusionTNBC open datasets allowed us to stratify samples into distinct immunotherapy response subgroups according to gene expression profiles. Based on two novel subtypes, candidates for ICB with a higher response rate and better prognosis could be selected by using the free visual online web server that we designed.

Machine learning-based in-hospital mortality prediction of HIV/AIDS patients with Talaromyces marneffei infection in Guangxi, China

“…Moreover, Machine learning methods might overcome some of the limitations of current analytical approaches to risk prediction by applying computer algorithms to large datasets with numerous, multidimensional variables, capturing high-dimensional, nonlinear relationships among clinical features to make data-driven death outcome predictions. Machine learning models based on clinical features have been used in many applications in cancer and tumor prognosis prediction, such as in lung cancer and breast cancer [ 19 , 20 ]. The application of death prediction in infectious diseases is also becoming a trend, typically regarding the prediction of mortality risk and prognosis of COVID-19 patients [ 21 – 23 ].…”

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer

“…The created fibroblast subtype was verified using an independent breast cancer dataset (the METABRIC dataset) [ 22 ]. 313 ER-negative and HER2-negative breast cancers with obtainable overall survival (OS) information and gene expression matrix were retrieved from METABRIC [ 16 ].…”

“…Using random forest (RF), decision tree (DT), and k -nearest neighbors (KNN) approaches from the R package “caret,” we constructed CAF subtype predictors. The package ‘caret' is a prevalent application for building prediction models and contains many prevalent machine learning approaches [ 16 ]. During the model training process, prognostic-related genes expression data were utilized.…”

“…However, only 18.5 percent of TNBC samples from the KEYNOTE012 trial reacted to PD1/PDL1 antibodies, which is far from satisfactory [ 15 ]. According to the new research, TNBC is not a unique illness, and the identification of subgroups/subtypes within TNBC samples might contribute to finding the right patients for PD1/PDL1 antibodies [ 16 ].…”

Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy

“…Machine learning algorithms that can effectively learn from a given database and provide accurate and reliable predictions in another dataset should be considered. Moreover, dividing patients into distinct molecular subtypes with different drug responses is a feasible method and is gaining popularity [ 12 , 13 ]. Thus, the identification of molecular subtypes by TME components and the construction of a machine learning prediction model might contribute to the clinical application of ICB.…”